Aclaris Therapeutics (ACRS) Earnings Analysis
Aclaris Therapeutics (ACRS) next reports earnings on 2026-08-06, consensus EPS -0.16 USD. Last quarter (2026-05-07) it beat with EPS -0.15 USD vs -0.16 USD est (+6.3%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -10.04.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ACRS next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.16 USD |
| Revenue estimate | 0.00B |
ACRS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.15 USD | -0.16 USD | +6.3% | Beat |
| 2026-02-26 | -0.16 USD | -0.15 USD | -6.7% | Miss |
| 2025-02-27 | -0.1 USD | -0.09 USD | -11.1% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
ACRS valuation and analyst view
| Trailing P/E | -10.04 |
|---|---|
| Trailing EPS | -0.54081 USD |
| Price / book | 5.04 |
| Dividend yield | 0.00% |
| Market cap | 0.67B |
| Analyst consensus | Buy (13 buy / 3 hold / 0 sell) |
| Avg price target | 11 USD |
Related research pages
Frequently asked questions
When is Aclaris Therapeutics (ACRS)'s next earnings date?
Aclaris Therapeutics is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.16 USD and revenue estimate of 0.00B.
Did ACRS beat earnings last quarter?
In its 2026-05-07 report, ACRS posted EPS of -0.15 USD versus a -0.16 USD estimate — a beat of 6.3%.
What is ACRS's earnings track record?
Over the last 3 reported quarters with consensus data, ACRS beat estimates 1 times (33%).
What is ACRS's current P/E ratio and EPS?
ACRS trades at a trailing P/E of -10.04 on trailing EPS of -0.5408118388277934 USD.
What do analysts rate ACRS?
Analyst consensus is "Buy" across 16 ratings (0 strong buy, 13 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 11 USD.